Premium
First molar of a six‐week‐old mouse over‐expressing human fibroblast growth factor 23, stained with haematoxylin‐eosin. See Chen et al., pp 395–402.
Publication year - 2011
Publication title -
clinical and experimental pharmacology and physiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.752
H-Index - 103
eISSN - 1440-1681
pISSN - 0305-1870
DOI - 10.1111/j.1440-1681.2011.05543.x
Subject(s) - haematoxylin , eosin , fibroblast , fibroblast growth factor 23 , h&e stain , endocrinology , chemistry , staining , medicine , microbiology and biotechnology , biology , pathology , biochemistry , parathyroid hormone , in vitro , calcium
Cover image: First molar of a six‐week‐old mouse over‐expressing human fibroblast growth factor 23, stained with haematoxylin‐eosin. See Chen et al., pp 395–402.• PPARγ downregulates sEH in heart • Fluoxetine inhibits PAH by OPN downregulation • Liver enzymes and metabolic syndrome • Effects of NO on A 2A R and ACh in the RVLM • Fasudil and cardiac fibroblast functions • Effect of fibroblast growth factor 23 on teeth